Page last updated: 2024-10-16

aminolevulinic acid and Histiocytosis, Sinus

aminolevulinic acid has been researched along with Histiocytosis, Sinus in 2 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Histiocytosis, Sinus: Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Song, H1
Wang, T1
Sun, L1
Shi, J1
Su, Z1
Zhang, M1
Lu, Y1

Other Studies

2 other studies available for aminolevulinic acid and Histiocytosis, Sinus

ArticleYear
5-Aminolevulinic acid photodynamic therapy combined with CO
    Photodiagnosis and photodynamic therapy, 2022, Volume: 37

    Topics: Aminolevulinic Acid; Carbon Dioxide; Histiocytosis, Sinus; Humans; Laser Therapy; Photochemotherapy;

2022
Successful treatment of Rosai-Dorfman disease using ALA-PDT.
    Photodiagnosis and photodynamic therapy, 2018, Volume: 21

    Topics: Adult; Aminolevulinic Acid; Female; Histiocytosis, Sinus; Humans; Photochemotherapy; Photosensitizin

2018